Alcohol Facts and Statistics
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Global Status Report on Alcohol and Health 2018 Global Status Report on Alcohol and Health 2018 ISBN 978-92-4-156563-9
GLOBAL STATUS REPORT ON ALCOHOL AND HEALTH REPORT GLOBAL STATUS Global status report on alcohol and health 2018 Global status report on alcohol and health 2018 Global status report on alcohol and health 2018 ISBN 978-92-4-156563-9 © World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC- SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specic organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. Global status report on alcohol and health 2018. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris. -
Alcohol and Health
TABLE OF CONTENTS Alcohol and Health: Current Evidence ALCOHOL AND HEALTH MARCH-APRIL 2005 OUTCOMES Does Alcohol Consumption Increase the Risk of Ischemic ALCOHOL AND HEALTH OUTCOMES Stroke?, 1 Alcohol May Increase Oral Mu- Does Alcohol Consumption Increase the Risk of Ischemic Stroke? cosal Transmission of HIV, 1 Prior studies of the association between alco- beverage types did not significantly Alcohol Intake, Survival, and hol consumption and ischemic stroke have affect risk. Quality of Life, 2 produced inconsistent results and have limita- • The risk of ischemic stroke was low- tions. To address these issues, researchers est, though not statistically significant, Does Alcohol Consumption assessed alcohol intake and prevalence of inci- in people who consumed 1–2 drinks Decrease the Risk of Coronary dent ischemic stroke (412 cases identified) in on 3–4 days each week (RR 0.7 com- Artery Calcification?, 2 38,156 male health professionals, aged 40–75 pared with those who abstained). years, over a 14-year period. Comments: Although this study reported • In analyses adjusted for potential con- some benefit from red wine use, its clearest founders, the risk of ischemic stroke finding was the increase in risk of ischemic INTERVENTIONS among drinkers versus that of nondrinkers stroke with increasing alcohol consumption, increased as alcohol consumption in- starting at 1–2 drinks per day. The com- Disulfiram or Naltrexone for creased (relative risk [RR] 1.0 for <1 drink plexities associated with beverage type and Alcohol Dependence?, 3 per day, RR 1.3 for 1–2 drinks per day, pattern of use, as indicated in these findings, and RR 1.4 for >2 drinks per day, P=0.01 highlight the challenge in making recom- Talking About Alcohol in Pri- for trend). -
Prevention of Alcohol Abuse and Illicit Drug Use Annual Awareness and Prevention Program Notice to System Offices Employees
Prevention of Alcohol Abuse and Illicit Drug Use Annual Awareness and Prevention Program Notice to System Offices Employees Alcohol abuse and illicit drug use disrupt the work and learning environment and create an unsafe and unhealthy workplace. To protect its employees and students and fully serve the citizens of Texas, The Texas A&M University System prohibits alcohol abuse and illicit drug use. This brochure, which is distributed annually, serves as an awareness and prevention tool for System Offices employees by providing basic information about A&M System policy and regulations, legal sanctions and health risks related to alcohol abuse and illicit drug use. Information about counseling, treatment and rehabilitation programs is included. As an employee of The Texas A&M University System, motivation. Drug use by a pregnant woman may cause you must abide by state and federal laws on controlled additional health complications in her unborn child. substances, illicit drugs and use of alcohol. In addition, you must comply with A&M System policy, which states: A&M System Sanctions The Texas A&M University System (system) strictly The A&M System’s drug and alcohol abuse policy and prohibits the unlawful manufacture, distribution, regulation are included in the System Orientation course possession or use of illicit drugs or alcohol on reviewed by new employees as part of their orientation. system property, and/or while on official duty and/or The policy and regulation are posted online at as part of any system activities. http://policies.tamus.edu/34-02.pdf and http://policies.tamus.edu/34-02-01.pdf. -
Binge Drinking and the Risk of Liver Events: a Population-Based Cohort Study
Received: 10 January 2017 | Accepted: 26 February 2017 DOI: 10.1111/liv.13408 GENETIC AND METABOLIC LIVER DISEASE Binge drinking and the risk of liver events: A population- based cohort study Fredrik Åberg1 | Jaana Helenius-Hietala2 | Pauli Puukka3 | Antti Jula3 1Transplantation and Liver Surgery Clinic, Helsinki University Hospital, Helsinki Abstract University, Helsinki, Finland Background & Aims: Binge drinking or heavy episodic drinking is increasingly preva- 2 Department of Oral and Maxillofacial lent, but the health effects are incompletely understood. We investigated whether Diseases, Helsinki University Hospital, Helsinki University, Helsinki, Finland binge drinking increases the risk for liver disease above and beyond the risk due to 3Department of Health, National Institute for average alcohol consumption. Health and Welfare, Turku, Finland Methods: 6366 subjects without baseline liver disease who participated in the Finnish Correspondence population- based Health 2000 Study (2000- 2001), a nationally representative cohort. Fredrik Åberg, MD, PhD, Transplantation Follow- up data from national registers until 2013 were analysed for liver- related ad- and Liver Surgery Clinic, Helsinki University Hospital, Helsinki University, Helsinki, Finland. missions, mortality and liver cancer. Binge drinking (≥5 drinks per occasion, standard Email: [email protected] drink 12 g ethanol) was categorised as weekly, monthly, or as less often or none. Funding information Multiple confounders were considered. FÅ received research grants from Wilhelm and Else Stockmanns Foundation, Liv och Hälsa, Results: Eighty- four subjects developed decompensated liver disease. Binge drinking and Finska Läkaresällskapet. frequency showed a direct association with liver- disease risk after adjustment for aver- Handling Editor: Helena Cortez-Pinto age daily alcohol intake and age. -
Management of Alcohol Use Disorders: a Pocket Reference for Primary Care Providers
Management of alcohol use disorders: A pocket reference for primary care providers Meldon Kahan, MD Edited by Kate Hardy, MSW and Sarah Clarke, PhD Acknowledgments Mentoring, Education, and Clinical Tools for Addiction: Primary Care–Hospital Integration (META:PHI) is an ongoing initiative to improve the experience of addiction care for both patients and providers. The purpose of this initiative is to set up and implement care pathways for addiction, foster mentoring relationships between addiction physicians and other health care providers, and create and disseminate educational materials for addiction care. This pocket guide is excerpted from Safe prescribing practices for addictive medications and management of substance use disorders in primary care: A pocket reference for primary care providers, a quick-reference tool for primary care providers to assist them in implementing best practices for prescribing potentially addictive medications and managing substance use disorders in primary care, endorsed by the College of Family Physicians of Canada. This excerpt is a guide to talking to patients about their alcohol use and managing at-risk drinking and alcohol use disorders. We thank those who have given feedback on this document: Dr. Mark Ben-Aron, Dr. Peter Butt, Dr. Delmar Donald, Dr. Mike Franklyn, Dr. Melissa Holowaty, Dr. Anita Srivastava, and three anonymous CFPC reviewers. We gratefully acknowledge funding and support from the following organizations: Adopting Research to Improve Care (Health Quality Ontario & Council of Academic Hospitals of Ontario) The College of Family Physicians of Canada Toronto Central Local Health Integration Network Women’s College Hospital Version date: December 19, 2017 © 2017 Women’s College Hospital All rights reserved. -
Alcohol Abuse and Acute Lung Injury and Acute Respiratory Distress
Journal of Anesthesia & Critical Care: Open Access Review Article Open Access Alcohol abuse and acute lung injury and acute respiratory distress syndrome Introduction Volume 10 Issue 6 - 2018 Alcohol is one of the most commonly used and abused beverage Fadhil Kadhum Zwer Aliqa worldwide. Alcohol is known to have numerous systemic health Private clinic practice, Iraq effects, including on the liver and central nervous system. From a respiratory standpoint, alcohol abuse has long been associated with Correspondence: Fadhil Kadhum Zwer Aliqaby, Private clinic practice, Iraq, Email an increased risk of pneumonia. More recently, alcohol abuse has been strongly linked in epidemiologic studies to development of Received: December 11, 2017 | Published: November 28, ARDS in at-risk patients. The first demonstration of an association 2018 between chronic alcohol abuse and ARDS was made by Moss et al, who retrospectively examined 351 patients at risk for ARDS.1 In this subsequent decreased phagocytosis and bacterial killing. Chronic cohort, 43% of patients who chronically abused alcohol developed alcohol use is similarly associated with altered neutrophil function and ARDS compared to only 22% of those who did not abuse alcohol, decreased superoxide production. Interestingly, chronic alcohol use with the effect most pronounced in patients with sepsis. This study decreases levels of granulocyte/macrophage colony stimulating factor was limited by its retrospective design, particularly since this design (GM-CSF) receptor and signaling in lung epithelium, which has been required that alcohol use history be obtained by chart review and shown to result in defective alveolar macrophage maturation. The documented history; furthermore, this study did not adjust for net effect of these abnormalities is an increased pulmonary bacterial concomitant cigarette smoking. -
Alcohol Withdrawal Syndrome (AWS) in the Acute Care Setting
Visionary Leadership for Psychiatric-Mental Health Nurses Around the World I N T E R N A T I O N A L S O C I E T Y O F P S Y C H I A T R I C - M E N T A L H E A L T H N U R S E S Position Paper, October 2000 Assessment and Identification Management of Alcohol Withdrawal Syndrome (AWS) in the Acute Care Setting Background Alcoholism is a chronic, neurobiological disorder that leads to a variety of healthcare problems often leading to acute care hospitalization. It is not surprising that alcohol withdrawal syndrome (AWS), is a common occurrence in acute care patients. AWS is a potentially life threatening condition, often coupled with co-morbidities that can adversely affect the outcome of treatment. The focus of this position paper is to address the acute care patient who is at risk for or has developed AWS. Therefore, the recommendations are directed to the patient with alcohol withdrawal. However, many acute care patients are suffering from polysubstance abuse and a strong denial system (patient and family) which often produces either a complex or unexpected withdrawal syndrome presentation. Those patients require immediate referral to addiction or psychiatric nurse/physician specialists in the medical center due to the complex nature of their addiction and possible withdrawal state. The goals of this ISPN position statement are to: promote nursing and medical care that is evidence-based, promote an environment that addresses early identification and aggressive treatment of AWS that is effective and safe, and decrease the use of automatic chemical or mechanical restraints in the treatment of patients with AWS. -
Alcohol and Health
DRINK AND DRUGS NEWS – WIDER HEALTH SERIES ALCOHOL AND HEALTH e all know that alcohol is linked to health problems; important messages from this supplement is to get people to check in however, the range and scale of those harms is far wider with their GP. However, knowing what some of the symptoms look like, than many of us think. In particular, drinking very heavily and having a sense of what kinds of questions to ask, is invaluable. As with brings with it a number of serious physical risks. This all things, early intervention is essential to preventing potentially tragic Wspecial supplement, which Alcohol Research UK is proud to be sponsoring, consequences down the line. Therefore, the advice contained here will be provides a clear and detailed overview of those risks, as well as advice for of enormous help to anyone working with individuals facing health risks people likely to encounter such problems in their day-to-day work. from their drinking and, of course, to those individuals themselves. As this supplement shows, heavy drinking can cause more than Dr James Nicholls, director of research and policy development, Alcohol liver damage. Its impact on mental health, hypertension, and cancer Research UK risk are only now becoming widely recognised. The revised ‘low risk’ guidelines of 14 units per week for men and women reflect this growing Supported by awareness and are based on a comprehensive analysis of the full range of conditions associated with alcohol consumption. Of course, many people reading this supplement will be dealing with individuals drinking at far higher levels than those set out in the guidelines, and here the risks become very significant. -
Pennsylvania Drug and Alcohol Abuse Control Act."
§ 1690.101. Short title This act shall be known and may be cited as the "Pennsylvania Drug and Alcohol Abuse Control Act." § 1690.102. Definitions (a) The definitions contained and used in the Controlled Substance, Drug, Device and Cosmetic Act shall also apply for the purposes of this act. (b) As used in this act: "CONTROLLED SUBSTANCE" means a drug, substance, or immediate precursor in Schedules I through V of the Controlled Substance, Drug, Device and Cosmetic Act. "COUNCIL" means the Pennsylvania Advisory Council on Drug and Alcohol Abuse established by this act. "COURT" means all courts of the Commonwealth of Pennsylvania, including magistrates and justices of the peace. "DEPARTMENT." The Department of Health. "DRUG" means (i) substances recognized in the official United States Pharmacopeia, or official National Formulary, or any supplement to either of them; and (ii) substances intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in man or other animals; and (iii) substances (other than food) intended to affect the structure or any function of the body of man or other animals; and (iv) substances intended for use as a component of any article specified in clause (i), (ii) or (iii), but not including devices or their components, parts or accessories. "DRUG ABUSER" means any person who uses any controlled substance under circumstances that constitute a violation of the law. "DRUG DEPENDENT PERSON" means a person who is using a drug, controlled substance or alcohol, and who is in a state of psychic or physical dependence, or both, arising from administration of that drug, controlled substance or alcohol on a continuing basis. -
6.14 Alcohol Use Disorders and Alcoholic Liver Disease
6. Priority diseases and reasons for inclusion 6.14 Alcohol use disorders and alcoholic liver disease See Background Paper 6.14 (BP6_14Alcohol.pdf) Background The WHO estimates that alcohol is now the third highest risk factor for premature mortality, disability and loss of health worldwide.1 Between 2004 to 2006, alcohol use accounted for about 3.8% of all deaths (2.5 million) and about 4.5% (69.4 million) of Disability Adjusted Life Years (DALYS).2 Europe is the largest consumer of alcohol in the world and alcohol consumption in this region emerges as the third leading risk factor for disease and mortality.3 In European countries in 2004, an estimated one in seven male deaths (95 000) and one in 13 female deaths (over 25 000) in the 15 to 64 age group were due to alcohol-related causes.3 Alcohol is a causal factor in 60 types of diseases and injuries and a contributing factor in 200 others, and accounts for 20% to 50% of the prevalence of cirrhosis of the liver. Alcohol Use Disorders (AUD) account for a major part of neuropsychiatric disorders and contribute substantially to the global burden of disease. Alcohol dependence accounts for 71% of all alcohol-related deaths and for about 60% of social costs attributable to alcohol.4 The acute effects of alcohol consumption on the risk of both unintentional and intentional injuries also have a sizeable impact on the global burden of disease.2 Alcoholic liver disease (ALD) is the commonest cause of cirrhosis in the western world, and is currently one of the ten most common causes of death.5 Liver fibrosis caused by alcohol abuse and its end stage, cirrhosis, present enormous problems for health care worldwide. -
Alcohol Withdrawal
Alcohol withdrawal TERMINOLOGY CLINICAL CLARIFICATION • Alcohol withdrawal may occur after cessation or reduction of heavy and prolonged alcohol use; manifestations are characterized by autonomic hyperactivity and central nervous system excitation 1, 2 • Severe symptom manifestations (eg, seizures, delirium tremens) may develop in up to 5% of patients 3 CLASSIFICATION • Based on severity ○ Minor alcohol withdrawal syndrome 4, 5 – Manifestations occur early, within the first 48 hours after last drink or decrease in consumption 6 □ Manifestations develop about 6 hours after last drink or decrease in consumption and usually peak about 24 to 36 hours; resolution occurs in 2 to 7 days 7 if withdrawal does not progress to major alcohol withdrawal syndrome 4 – Characterized by mild autonomic hyperactivity (eg, tachycardia, hypertension, diaphoresis, hyperreflexia), mild tremor, anxiety, irritability, sleep disturbances (eg, insomnia, vivid dreams), gastrointestinal symptoms (eg, anorexia, nausea, vomiting), headache, and craving alcohol 4 ○ Major alcohol withdrawal syndrome 5, 4 – Progression and worsening of withdrawal manifestations, usually after about 24 hours from the onset of initial manifestations 4 □ Manifestations often peak around 50 hours before gradual resolution or may continue to progress to severe (complicated) withdrawal, particularly without treatment 4 – Characterized by moderate to severe autonomic hyperactivity (eg, tachycardia, hypertension, diaphoresis, hyperreflexia, fever); marked tremor; pronounced anxiety, insomnia, -
Global Status Report on Alcohol and Health WHO Library Cataloguing-In-Publication Data
Global status report on alcohol and health WHO Library Cataloguing-in-Publication Data Global status report on alcohol and health. 1.Alcoholism - epidemiology. 2.Alcohol drinking - adverse effects. 3.Social control, Formal - methods. 4.Cost of illness. 5.Public policy. I.World Health Organization. ISBN 978 92 4 156415 1 (NLM classification: WM 274) © World Health Organization 2011 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication.